8-K: SHF Holdings Reports Q3 Results, Faces Nasdaq Delisting Risk

SHF Holdings announced third-quarter revenue growth driven by loan program income, but also highlighted significant dilution from Series B conversions and an ongoing struggle to meet Nasdaq's minimum bid price requirement.

Summary

• SHF Holdings reported third-quarter revenue of $1.95 million, a 6.5% increase year-over-year, primarily due to a 70.2% surge in loan program income.
• Average client deposit balances grew 3.8% to $112 million, with trailing 14-day average deposits reaching $119.3 million.
• The company narrowed its operating loss by 17.7% to $1 million, but reported a net loss of approximately $979,000.
• Significant dilution occurred due to Series B Convertible Preferred Stock conversions, increasing common shares outstanding from 1,028,702 to 132,248,520.
• SHF Holdings received an extension until April 19, 2027, to regain compliance with Nasdaq's $1 minimum bid price requirement, but faces delisting if the stock remains below $0.10 for ten consecutive days.
• A proposed business combination with Opifex Media Inc. is underway, where Opifex security holders would own approximately 85% of the combined company.
• The company estimates a potential loss of $0 to $7.8 million, plus interest, from the Abaca litigation.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to significant dilution, ongoing operating losses, and uncertainty surrounding Nasdaq listing compliance and a proposed merger.

Positives

• Revenue increased by 6.5% to $1.95 million in Q3 2026 compared to Q3 2025.
• Loan program income saw a substantial increase of 70.2% to approximately $869,000.
• Average client deposit balances increased by 3.8% to $112 million.
• Trailing 14-day average client deposits increased by 7.4% to $119.3 million.
• Operating loss narrowed by 17.7% to $1 million.
• Total operating expenses decreased by 3.2% to $2.95 million.
• Compensation and employee benefits expense decreased by 10.6% to $1.52 million.
• The company received recognition as Top Business Solutions Company at the 2026 PBC Cannabis Banking Conference.

Negatives

• Reported a net loss of approximately $979,000 for the third quarter.
• Account fee income decreased by 17.1% to approximately $798,000.
• Professional services expenses increased by 63.3% to approximately $722,000.
• Cash and cash equivalents decreased to $4.4 million as of September 30, 2026, from $6.78 million at year-end 2025.
• Net cash used in operating activities was $4.05 million for the first nine months of 2026, compared to $2.35 million in the prior-year period.
• The company's financial statements include a going concern disclosure due to recurring operating losses and negative cash flows.
• Significant dilution occurred from Series B Convertible Preferred Stock conversions, increasing common shares outstanding from 1,028,702 to 132,248,520.
• The company's common stock has recently closed below $0.10 on eight consecutive business days, risking delisting.

Risks

• The company faces a significant risk of delisting from Nasdaq if it cannot regain compliance with the $1 minimum bid price requirement by April 19, 2027.
• A continued closing bid price of $0.10 or less for ten consecutive business days could lead to an immediate delisting determination by Nasdaq.
• If delisted from Nasdaq, the stock would likely be quoted on an over-the-counter market, offering less liquidity and visibility.
• The proposed transaction with Opifex Media Inc. is subject to numerous conditions, including definitive agreements, due diligence, and approvals, with no assurance of completion.
• The Abaca litigation poses a risk of a potential loss estimated between $0 and $7.8 million, plus interest, which could exceed available liquidity.
• The Series B Convertible Preferred Stock terms include price adjustment provisions and other obligations that create ongoing risks and potential dilution.
• The company's ability to continue as a going concern is uncertain due to recurring operating losses and negative operating cash flows.
• The proposed transaction with Opifex could result in significant dilution for existing SHF Holdings shareholders, with Opifex security holders expected to own approximately 85% of the combined company.

Future Outlook

The company is focused on strengthening its core financial services platform, supporting existing clients, and positioning its institutional banking capabilities. A proposed business combination with Opifex Media Inc. aims to create a diversified public holding company. However, significant uncertainties remain regarding Nasdaq listing compliance, the completion of the Opifex transaction, and the outcome of the Abaca litigation.

Management Comments

• "Our third-quarter results demonstrate the continued value of Safe Harbors established financial services platform, with higher revenue, significant growth in loan program income and increased client deposit balances."
• "Our enhanced lending economics are contributing to revenue growth, while our deposit performance reflects the strength of the client relationships and specialized banking infrastructure we have built over more than a decade."
• "At the same time, we recognize the challenges facing our capital structure and public listing and remain focused on evaluating solutions that preserve the value of our operating business."
• "Our priorities are maintaining service to our clients and financial institution partners, managing liquidity and pursuing strategic opportunities that may support a more sustainable path forward."
• "We remain committed to the clients and financial institution partners who rely on our platform. Our focus is on maintaining operational continuity, protecting the capabilities we have built and evaluating opportunities that may provide a more sustainable foundation for the business and its stakeholders."

Industry Context

StockSavvy.ai notes that SHF Holdings operates in the niche but growing fintech sector serving the regulated cannabis and hemp industries. This sector often faces unique regulatory and financial challenges, including access to banking services and capital. The company's focus on providing specialized banking and lending solutions is a key differentiator, but the broader industry is also subject to evolving legal landscapes and increased competition.

Comparison to Industry Standards

• The 6.5% revenue growth in Q3 2026 is moderate compared to some high-growth fintech sectors, but potentially strong given the specialized and regulated nature of the cannabis industry.
• The 70.2% growth in loan program income is a significant positive, indicating improved profitability from lending activities, which is a critical revenue stream for financial service providers.
• The narrowing operating loss is a positive trend, suggesting improved operational efficiency, though the company continues to operate at a loss.
• The net loss of $979,000 in Q3 2026, contrasted with a net income of $180,000 in Q3 2025, is a significant negative, largely due to a one-time gain on debt extinguishment in the prior year.
• The ongoing struggle to maintain Nasdaq's minimum bid price requirement is a critical concern, highlighting capital structure challenges common to smaller, growth-oriented companies in challenging markets.
• The proposed merger with Opifex Media Inc. suggests a strategy to diversify and potentially access new capital and markets, a common tactic for companies facing financial or listing pressures.

Legal Proceedings

• The Abaca litigation concerning damages and remaining claims has had a trial, with an estimated range of reasonably possible loss between $0 and $7.8 million, plus interest. A ruling is pending.

Related Party Transactions

• Partner Colorado Credit Union (PCCU) was previously a related party but sold all of its Series B Convertible Preferred Stock to another Series B holder in a private transaction. PCCU remains the company's largest customer and depository for substantially all of its cash.

Stakeholder Impact

• Shareholders face significant dilution from Series B conversions and uncertainty regarding the company's Nasdaq listing and the proposed merger.
• Creditors and other stakeholders face uncertainty due to the company's going concern disclosure and potential for delisting.
• Clients and financial institution partners rely on the company's continued operational continuity, which is subject to ongoing financial and listing challenges.

Next Steps

• Negotiate and execute definitive agreements for the proposed transaction with Opifex Media Inc.
• Obtain necessary stockholder approvals for the proposed transaction and any required reverse stock split.
• Complete satisfactory due diligence for the Opifex transaction.
• Secure required consents and agreements with holders of Series B securities.
• Obtain Opifex's audited financial statements.
• Secure an independent valuation and fairness opinion for the transaction.
• Obtain Nasdaq approval for the continued or initial listing of the combined company.
• Regain compliance with Nasdaq's minimum bid price requirement by April 19, 2027.

Key Dates

Recommendation

The company is facing severe financial distress, including ongoing operating losses, significant dilution from preferred stock conversions, and a critical risk of delisting from Nasdaq. While revenue is growing, it is not sufficient to offset losses. The proposed merger with Opifex offers a potential path forward but involves substantial dilution for existing shareholders and significant execution risks. The pending Abaca litigation adds further uncertainty. Given these factors, the risk/reward profile is unfavorable for current investors.

Keywords

cannabis banking, fintech, loan program income, deposit balances, Nasdaq listing, business combination, dilution, operating loss